Lagevrio (molnupiravir) is used to treat mild to moderate coronavirus disease 2019 (COVID-19). The FDA is allowing this medicine to be used while the benefits and risks are being studied. Lagevrio may also be used for other conditions as determined by your health care provider.
Send Message